恶性胸腺瘤：分类与多模态治疗的现状
Malignant thymoma: current status of classification and multimodality treatment.
作者信息
Schmidt-Wolf I G H, Rockstroh J K, Schüller H, Hirner A, Grohe C, Müller-Hermelink H K, Huhn D
机构信息
Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.
Klinik und Poliklinik für Radiologie, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.
出版信息
Ann Hematol. 2003 Feb;82(2):69-76. doi: 10.1007/s00277-002-0597-6. Epub 2003 Feb 11.
Classification, understanding of the pathophysiology, and treatment options of thymoma have changed during recent years. It is hoped that novel strategies will lead to a survival benefit in these patients. It has become clear that patients with thymoma are best treated with multimodality therapy. In this review, a pathologist, an immunologist, a surgeon, a radiotherapist, a pneumologist, and oncologists discuss the current status of classification and strategies for the treatment of patients with thymoma.
近年来，胸腺瘤的分类、病理生理学理解及治疗选择都发生了变化。人们希望新的策略能给这些患者带来生存获益。目前已明确，胸腺瘤患者采用多模式治疗效果最佳。在本综述中，一位病理学家、一位免疫学家、一位外科医生、一位放疗科医生、一位呼吸科医生和肿瘤学家共同探讨了胸腺瘤患者的分类现状及治疗策略。
Zotero 插件